"Global U.S. Digital Therapeutics Market Overview:
Global U.S. Digital Therapeutics Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global U.S. Digital Therapeutics Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of U.S. Digital Therapeutics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the U.S. Digital Therapeutics Market:
The U.S. Digital Therapeutics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for U.S. Digital Therapeutics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study U.S. Digital Therapeutics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, U.S. Digital Therapeutics market has been segmented into:
(Treatment & Disease Management (Chronic Care
Mental Health & Neurological Disorders
and Others
By Application, U.S. Digital Therapeutics market has been segmented into:
Pre-diabetes
Weight Management
and Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The U.S. Digital Therapeutics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the U.S. Digital Therapeutics market.
Top Key Players Covered in U.S. Digital Therapeutics market are:
2Morrow Inc.
ResMed
Pear Therapeutics
Omada Health Inc.
Teladoc Health
Lark Technologies
Kaia Health
Fitbit
Cognoa Inc.
Akili Interactive Labs
among others.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: U.S. Digital Therapeutics Market by Type
4.1 U.S. Digital Therapeutics Market Snapshot and Growth Engine
4.2 U.S. Digital Therapeutics Market Overview
4.3 (Treatment & Disease Management (Chronic Care
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 (Treatment & Disease Management (Chronic Care: Geographic Segmentation Analysis
4.4 Mental Health & Neurological Disorders
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Mental Health & Neurological Disorders: Geographic Segmentation Analysis
4.5 and Others
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 and Others: Geographic Segmentation Analysis
Chapter 5: U.S. Digital Therapeutics Market by Application
5.1 U.S. Digital Therapeutics Market Snapshot and Growth Engine
5.2 U.S. Digital Therapeutics Market Overview
5.3 Pre-diabetes
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Pre-diabetes: Geographic Segmentation Analysis
5.4 Weight Management
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Weight Management: Geographic Segmentation Analysis
5.5 and Others
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 and Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 U.S. Digital Therapeutics Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 2MORROW INC.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 RESMED
6.4 PEAR THERAPEUTICS
6.5 OMADA HEALTH INC.
6.6 TELADOC HEALTH
6.7 LARK TECHNOLOGIES
6.8 KAIA HEALTH
6.9 FITBIT
6.10 COGNOA INC.
6.11 AND AKILI INTERACTIVE LABS
6.12 AMONG OTHERS.
Chapter 7: Global U.S. Digital Therapeutics Market By Region
7.1 Overview
7.2. North America U.S. Digital Therapeutics Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 (Treatment & Disease Management (Chronic Care
7.2.4.2 Mental Health & Neurological Disorders
7.2.4.3 and Others
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Pre-diabetes
7.2.5.2 Weight Management
7.2.5.3 and Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe U.S. Digital Therapeutics Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 (Treatment & Disease Management (Chronic Care
7.3.4.2 Mental Health & Neurological Disorders
7.3.4.3 and Others
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Pre-diabetes
7.3.5.2 Weight Management
7.3.5.3 and Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe U.S. Digital Therapeutics Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 (Treatment & Disease Management (Chronic Care
7.4.4.2 Mental Health & Neurological Disorders
7.4.4.3 and Others
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Pre-diabetes
7.4.5.2 Weight Management
7.4.5.3 and Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific U.S. Digital Therapeutics Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 (Treatment & Disease Management (Chronic Care
7.5.4.2 Mental Health & Neurological Disorders
7.5.4.3 and Others
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Pre-diabetes
7.5.5.2 Weight Management
7.5.5.3 and Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa U.S. Digital Therapeutics Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 (Treatment & Disease Management (Chronic Care
7.6.4.2 Mental Health & Neurological Disorders
7.6.4.3 and Others
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Pre-diabetes
7.6.5.2 Weight Management
7.6.5.3 and Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America U.S. Digital Therapeutics Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 (Treatment & Disease Management (Chronic Care
7.7.4.2 Mental Health & Neurological Disorders
7.7.4.3 and Others
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Pre-diabetes
7.7.5.2 Weight Management
7.7.5.3 and Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
U.S. Digital Therapeutics Scope:
|
Report Data
|
U.S. Digital Therapeutics Market
|
|
U.S. Digital Therapeutics Market Size in 2025
|
USD XX million
|
|
U.S. Digital Therapeutics CAGR 2025 - 2032
|
XX%
|
|
U.S. Digital Therapeutics Base Year
|
2024
|
|
U.S. Digital Therapeutics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
2Morrow Inc., ResMed, Pear Therapeutics, Omada Health Inc., Teladoc Health, Lark Technologies, Kaia Health, Fitbit, Cognoa Inc., and Akili Interactive Labs, among others..
|
|
Key Segments
|
By Type
(Treatment & Disease Management (Chronic Care
Mental Health & Neurological Disorders
and Others
By Applications
Pre-diabetes
Weight Management
and Others
|
